Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
S-formylglutathione hydrolase (Esterase D, ESD) is a serine hydrolase enzyme with an alpha/beta-hydrolase fold, primarily involved in the detoxification of formaldehyde by catalyzing the hydrolysis of S-formylglutathione to glutathione and formate. It is active toward multiple substrates, including O-acetylated sialic acids, potentially contributing to sialic acid recycling. The ESD gene is located near the RB1 gene on chromosome 13q14 and is widely used as a genetic marker for retinoblastoma and Wilson's disease. While its physiological substrate is S-formylglutathione, the enzyme shows broad substrate specificity, and its activity is essential for cellular processes related to aldehyde detoxification. There are currently no direct drugs targeting ESD, and its main clinical application is as a biomarker rather than a therapeutic target[1][2][4].
Not applicable for current therapeutics; no direct drugs known to target ESD. The enzyme catalyzes the hydrolysis of S-formylglutathione in formaldehyde detoxification, and acts as a serine hydrolase[2][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on S-formylglutathione hydrolase (ESD).